Latest from Tuberous Sclerosis Alliance

Coronavirus and Tuberous Sclerosis Complex: What You Need to Know

The Tuberous Sclerosis Alliance (TS Alliance) have prepared an FAQ to address concerns from the tuberous sclerosis complex (TSC) community regarding the COVID-19 outbreak.

Sabril Label Expanded for Patients 2 to 10 Years Old

The previously approved therapy is now indicated for treatment in pediatric patients age 2 to 10.

Bcureful and Tuberous Sclerosis Alliance Announce Plans to Combine Efforts

The announcement formally connects Bcureful and the Tuberous Sclerosis Alliance together after working closely together for over the past 8 years.

Important Information About Changes to Access and Availability of Generic Everolimus and Afinitor

The Tuberous Sclerosis Alliance has announced updates to access of everolimus, a drug used to treat several conditions associated with tuberous sclerosis complex.

Tweets by @tsalliance

Tweets by neurology_live